Page results
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
Patients with an aggressive form of leukaemia will now be able to receive a breakthrough immunotherapy on the NHS which was developed and trialled at UCLH and UCL.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
On Sunday 23 November, the Royal National Orthopaedic Hospital (RNOH) successfully connected to UCLH’s Epic electronic health record (EHR). This is another milestone in our collaboration and digital transformation across North Central London.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
UCLH has welcomed its 1000th patient to our proton beam therapy department, which opened in December 2021.
-
Information covering a range of conditions. Search by condition name or condition type (specialty).
-
This page provides information for pregnant women with Inflammatory Bowel Disease.
-
In a joint public appearance, the trio, who are Honorary Patrons of Teenage Cancer Trust, visited the ward to meet young patients and thank staff for their work.